OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, et al.
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 5, pp. 640-640
Open Access | Times Cited: 22
Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, et al.
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 5, pp. 640-640
Open Access | Times Cited: 22
Showing 22 citing articles:
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
Jennifer Perais, Ridhi Agarwal, Jennifer Evans, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 88
Jennifer Perais, Ridhi Agarwal, Jennifer Evans, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 88
Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort’s analysis
Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, et al.
International Journal of Retina and Vitreous (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, et al.
International Journal of Retina and Vitreous (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes
Rafael Simó, Josep Franch‐Nadal, Bogdan Vlacho, et al.
Diabetes Care (2023) Vol. 46, Iss. 9, pp. 1633-1639
Open Access | Times Cited: 15
Rafael Simó, Josep Franch‐Nadal, Bogdan Vlacho, et al.
Diabetes Care (2023) Vol. 46, Iss. 9, pp. 1633-1639
Open Access | Times Cited: 15
Weight loss, bariatric surgery, and novel antidiabetic drugs effects on diabetic retinopathy: a review
Alejandro M Perez, Emily Neag, Jayanth Sridhar, et al.
Current Opinion in Ophthalmology (2024) Vol. 35, Iss. 3, pp. 192-196
Closed Access | Times Cited: 5
Alejandro M Perez, Emily Neag, Jayanth Sridhar, et al.
Current Opinion in Ophthalmology (2024) Vol. 35, Iss. 3, pp. 192-196
Closed Access | Times Cited: 5
Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities
Nidhi Raval, Akshant Kumawat, Dnyaneshwar Kalyane, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 5, pp. 862-878
Closed Access | Times Cited: 39
Nidhi Raval, Akshant Kumawat, Dnyaneshwar Kalyane, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 5, pp. 862-878
Closed Access | Times Cited: 39
Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Artur Małyszczak, Joanna Przeździecka-Dołyk, Urszula Szydełko-Paśko, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1797-1797
Open Access | Times Cited: 4
Artur Małyszczak, Joanna Przeździecka-Dołyk, Urszula Szydełko-Paśko, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1797-1797
Open Access | Times Cited: 4
Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review
Dimitrios P. Ntentakis, Victor S. M. C. Correa, Anastasia Maria Ntentaki, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2023) Vol. 262, Iss. 3, pp. 717-752
Closed Access | Times Cited: 10
Dimitrios P. Ntentakis, Victor S. M. C. Correa, Anastasia Maria Ntentaki, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2023) Vol. 262, Iss. 3, pp. 717-752
Closed Access | Times Cited: 10
Incidence and progression of diabetic retinopathy in patients treated with glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter 2 inhibitors: A population‐based cohort study
Donna Shu‐Han Lin, Hao‐Yun Lo, Kuan‐Chih Huang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4386-4396
Closed Access | Times Cited: 3
Donna Shu‐Han Lin, Hao‐Yun Lo, Kuan‐Chih Huang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4386-4396
Closed Access | Times Cited: 3
Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?
Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 14
Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 14
Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study
Jingxing Li, Yu-Tung Hung, Henry Bair, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Jingxing Li, Yu-Tung Hung, Henry Bair, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
Eugene Yu‐Chuan Kang, Chunya Kang, Wei‐Chi Wu, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2871-2871
Open Access | Times Cited: 17
Eugene Yu‐Chuan Kang, Chunya Kang, Wei‐Chi Wu, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2871-2871
Open Access | Times Cited: 17
Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment
J. Mellor, Anita Jeyam, Joline W. J. Beulens, et al.
Ophthalmology Science (2024) Vol. 4, Iss. 4, pp. 100494-100494
Open Access | Times Cited: 2
J. Mellor, Anita Jeyam, Joline W. J. Beulens, et al.
Ophthalmology Science (2024) Vol. 4, Iss. 4, pp. 100494-100494
Open Access | Times Cited: 2
The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy—A Review
Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 705-705
Open Access | Times Cited: 14
Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 705-705
Open Access | Times Cited: 14
Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model
Patricia Bogdanov, Hugo Ramos, Marta Valeri, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 465-465
Open Access | Times Cited: 9
Patricia Bogdanov, Hugo Ramos, Marta Valeri, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 465-465
Open Access | Times Cited: 9
Association between dipeptidyl peptidase-4 inhibitor use and diabetic retinopathy: a systematic review and meta-analysis of real-world studies
M. Wang, Jiali Lu, Jiyue Dong
BMC Ophthalmology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
M. Wang, Jiali Lu, Jiyue Dong
BMC Ophthalmology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Sitagliptin eye drops prevent the impairment of retinal neurovascular unit in the new Trpv2+/− rat model
Hugo Ramos, Josy Augustine, Burak Muğdat Karan, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Hugo Ramos, Josy Augustine, Burak Muğdat Karan, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic Retinopathy
Hugo Ramos, Patricia Bogdanov, Rafael Simó, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 571-571
Open Access | Times Cited: 5
Hugo Ramos, Patricia Bogdanov, Rafael Simó, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 571-571
Open Access | Times Cited: 5
Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies
Samuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, et al.
Diabetes Obesity and Metabolism (2023)
Closed Access | Times Cited: 2
Samuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, et al.
Diabetes Obesity and Metabolism (2023)
Closed Access | Times Cited: 2
Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data
Cristina Hernández, Hugo Ramos, Anne Létondor, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1579-1579
Open Access
Cristina Hernández, Hugo Ramos, Anne Létondor, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1579-1579
Open Access
Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
Jun Sung Moon
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 6, pp. 911-911
Open Access
Jun Sung Moon
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 6, pp. 911-911
Open Access
Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
Yoo-Ri Chung, Kyoung Hwa Ha, Kihwang Lee, et al.
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 6, pp. 917-917
Open Access
Yoo-Ri Chung, Kyoung Hwa Ha, Kihwang Lee, et al.
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 6, pp. 917-917
Open Access
Effects of Fibrates on Risk of Development of Diabetic Retinopathy in Japanese Working Age Patients with Type 2 Diabetes and Dyslipidemia: a Retrospective Cohort Study
Hayato Akimoto, Yasuo Takahashi, Satoshi Asai
YAKUGAKU ZASSHI (2021) Vol. 141, Iss. 5, pp. 761-769
Open Access
Hayato Akimoto, Yasuo Takahashi, Satoshi Asai
YAKUGAKU ZASSHI (2021) Vol. 141, Iss. 5, pp. 761-769
Open Access
